PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Milani Qebetu

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · JOURNAL ARTICLE

Evaluation of the biodistribution of [99mTc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [68Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy

Ejnmmi Research

Small prospective intraindividual comparison showing [99mTc]Tc-PSMA-GCK01 SPECT/CT has comparable biodistribution to [68Ga]PSMA-11 PET/CT for lesion phenotyping in mCRPC, but limited by sample size (n=10) and single centre, requiring larger validation before clinical implementation.

PromisingProstate Cancer Treatment and Research Jens Cardinale Mike Machaba Sathekge

Reported

Sample size10

Median age68 years

Age range56–85 years

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support